This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Neal S. Penneys, MD, PhD
Department of Dermatology University of Miami School of Medicine PO Box 016940 (R11) Miami, FL 33101

Arch Dermatol. 1985;121(10):1239-1240.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

I was interested to read the article by Hoshaw et al¹ in the January 1985 ARCHIVES describing ochronosislike pigmentation from hydroquinone bleaching creams in American blacks. We have recently had the opportunity to evaluate a similar case. In reviewing the literature concerning the biochemical pathway involved in phenylalanine and tyrosine catabolism, I found the article written by Shepartz² in 1953. Shepartz has shown that hydroquinone inhibits the activity of homogentisic acid oxidase in vitro. This same enzyme has markedly decreased activity in alkaptonuria (Figure). I would like to propose the following hypothesis: Topically applied hydroquinone inhibits the activity of homogentisic acid oxidase in the skin, resulting in the local accumulation of homogentisic acid, which polymerizes to form ochronotic pigment. In effect, this process would mimic the cutaneous manifestation of endogenous ochronosis. This explanation is supported by the observation that hydroquinone-induced exogenous ochronosis is clinically and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?